Poland· PL-100244390
Foscan
A temoporfin product containing temoporfinum, registered in Poland by biolitec Pharma Ltd.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Temoporfin is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XD05 (temoporfin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Temoporfin · ATC L01XD05
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Temoporfinum
- Manufacturer
- biolitec Pharma Ltd.
- Country
- Poland (PL)
- ATC code
- L01XD05
- ATC class
- Temoporfin
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990856572
- gtin05909990856589
- gtin05909990856596
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Temoporfin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFoscan 1 mg/mlBiolitec Pharma
- CzechiaFOSCANbiolitec Pharma Ltd., Jena
- SpainFOSCAN 1 mg/ml SOLUCION INYECTABLEBiolitec Pharma Limited
- IcelandFoscanBiolitec Pharma Ltd.
- SwedenFoscan 1 mg/ml Injektionsvätska, lösningBiolitec Pharma Ltd
- United KingdomFoscan 1mg/1ml solution for injection vialsBiolitec Pharma Ltd
- FinlandFoscanbiolitec Pharma Ltd.
- NetherlandsFoscan 1 mg/ml, oplossing voor injectieBiolitec Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5bbcc35f-4b84-4922-9675-cd4afc978d9b GET /v1/drugs/5bbcc35f-4b84-4922-9675-cd4afc978d9b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "1 mg/ml",
"packaging": "05909990856572 ¦ Rpz ¦ EU/1/01/197/003 ¦ 65527\n1 fiol. 1 ml\n05909990856589 ¦ Rpz ¦ EU/1/01/197/004 ¦ 65528\n1 fiol. 3 ml\n05909990856596 ¦ Rpz ¦ EU/1/01/197/005 ¦ 65529\n1 fiol. 6 ml",
"substance": "Temoporfinum 1 mg/ml",
"common_name": "Temoporfinum",
"pl_product_id": "100244390",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about temoporfin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.